Company / Cash & Equivalents
Acadia Healthcare Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$133.2M
FY2025
5-year range
$76.3M / $133.8M
FY2021-FY2025
Trend
+74.6%
vs FY2024
Sector context
#100 of 148
Health Care
What the data says
At $133M, Acadia Healthcare's cash & equivalents ranks #100 of 148 in the Health Care sector. Cash & Equivalents has fluctuated over the past 10 years, ranging from $51M in FY2018 to $379M in FY2020.
Based on SEC 10-K filings.
$133M in FY2025 with a 5-year CAGR of -18.9%.
Improved from $100M to $133M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +10.9%
- 5-Year CAGR
- -18.9%
- 10-Year CAGR
- -
Sector benchmark
#100 of 148 in Health CareTop 68% of 148This company $133.2M Sector average $1.2B
▼
-88.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -18.9%, indicating a declining trend.
- In FY2025, cash & equivalents increased 74.6% year-over-year.
- Ranks #100 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $133.2M | +74.6% |
| FY2024 | $76.3M | -23.8% |
| FY2023 | $100.1M | +2.5% |
| FY2022 | $97.6M | -27.0% |
| FY2021 | $133.8M | -64.7% |
| FY2020 | $378.7M | +280.5% |
| FY2019 | $99.5M | +97.1% |
| FY2018 | $50.5M | -24.9% |
| FY2017 | $67.3M | +17.9% |
| FY2016 | $57.1M | +408.8% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026